X4’s mission is to bring innovative treatments to patients with cancer and primary immunodeficiencies. To fulfill this mission, we work with a sense of urgency and are passionately committed to rigorous science and the highest integrity in drug development. We engage with the health care community to ensure that we align with its highest needs and make a profound and positive impact on the lives of patients and their families.
We invite you to learn more about us and our unyielding fortitude to deliver new treatments for cancers and rare primary immunodeficiencies through the information and references outlined in this section.
Paula Ragan, PhD
Founder and CEO, X4 Pharmaceuticals